Unbound Bilirubin Levels in Healthy Term and Late Preterm Infants

Status unconfirmed

Conditions studied: Neonatal Jaundice

In brief

Specific Aim 1: To determine total serum bilirubin (TSB) and unbound bilirubin (Bf) levels in term and late preterm infants during the first week of life. Specific Aim 2: Measure Bf levels in breast fed and formula fed infants and examine their relationship to unbound fatty acid (FFAu) levels. Specific Aim 3: To demonstrate that phototherapy results in different changes in TSB and Bf.

Key facts

Study ID

NCT03237715

Run by

Rutgers University

People needed

180

Starts

2017-07-01

Expected to finish

2019-06-30

Last updated by the study team

2017-08-02

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Term and late-preterm infants admitted to the regular care nursery of Robert Wood Johnson University Hospital will be eligible for the study

You may not qualify if…

• Infants suffering from genetic, chromosomal or surgical conditions will be excluded.

Where it is running

• Robert Wood Johnson University Hospital — New Brunswick, New Jersey, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.